Xeris Pharmaceuticals
Price & Volume
Stats
See more52W Range | $3.14-$10.08 |
Market Cap | $1.1B |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $266.1M |
Revenue Growth (YoY) | 37.1% |
Gross Profit (12 Mos) | $225M |
Diluted EPS | -$0.10 |
News
See moreYahoo Finance • 2 days ago
7 Hidden Multibagger Stocks to Invest In
Yahoo Finance • 4 months ago
H.C. Wainwright assumes coverage on Xeris Pharmaceuticals stock with Buy rating
Yahoo Finance • 4 months ago
Xeris raises 2025 revenue guidance to $280M–$290M following 49% Q2 growth, led by Recorlev
Yahoo Finance • 4 months ago
XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) Surges 12% After Q2 Earnings Beat and Raised Revenue Guidance
About
CEO | Mr. John P. Shannon |
Address | 1375 West Fulton Street, Chicago, IL, United States, 60607 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 394 |
